WINTON GROUP Ltd Makes New $585,000 Investment in Doximity, Inc. (NASDAQ:DOCS)

WINTON GROUP Ltd purchased a new position in Doximity, Inc. (NASDAQ:DOCS - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 10,959 shares of the company's stock, valued at approximately $585,000.

A number of other large investors also recently modified their holdings of DOCS. Global Retirement Partners LLC lifted its stake in Doximity by 468.1% in the 4th quarter. Global Retirement Partners LLC now owns 534 shares of the company's stock worth $29,000 after purchasing an additional 440 shares in the last quarter. UMB Bank n.a. boosted its stake in Doximity by 69.1% during the fourth quarter. UMB Bank n.a. now owns 575 shares of the company's stock valued at $31,000 after buying an additional 235 shares during the period. Larson Financial Group LLC grew its position in Doximity by 49.4% during the fourth quarter. Larson Financial Group LLC now owns 756 shares of the company's stock worth $40,000 after buying an additional 250 shares in the last quarter. Optimum Investment Advisors bought a new position in Doximity in the 4th quarter worth about $43,000. Finally, Morse Asset Management Inc purchased a new stake in shares of Doximity in the 3rd quarter valued at about $46,000. 87.19% of the stock is currently owned by institutional investors.

Doximity Stock Up 2.2 %

Shares of Doximity stock traded up $1.24 during trading on Wednesday, reaching $57.96. 1,237,165 shares of the stock were exchanged, compared to its average volume of 1,939,754. The firm has a market cap of $10.82 billion, a price-to-earnings ratio of 57.96, a price-to-earnings-growth ratio of 4.10 and a beta of 1.34. Doximity, Inc. has a 1 year low of $22.96 and a 1 year high of $85.21. The stock's fifty day moving average is $65.59 and its 200 day moving average is $54.81.

Remove Ads

Insider Transactions at Doximity

In related news, Director Timothy S. Cabral sold 20,000 shares of the firm's stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the sale, the director now owns 6,360 shares of the company's stock, valued at $366,463.20. This trade represents a 75.87 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 37.40% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on DOCS shares. Piper Sandler raised Doximity from a "neutral" rating to an "overweight" rating and boosted their price objective for the stock from $31.00 to $78.00 in a report on Friday, February 7th. Stephens assumed coverage on shares of Doximity in a report on Friday, December 20th. They issued an "equal weight" rating and a $55.00 price target on the stock. Raymond James reaffirmed an "outperform" rating and set a $83.00 price objective (up from $65.00) on shares of Doximity in a report on Friday, February 7th. Bank of America increased their target price on Doximity from $54.00 to $57.00 and gave the company a "neutral" rating in a research note on Monday, January 6th. Finally, KeyCorp dropped their price target on Doximity from $70.00 to $65.00 and set an "overweight" rating for the company in a research note on Wednesday, January 8th. Eleven equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $64.22.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.